About Daniel Surinach
Form D filings for Objective Biotechnology in 2024 list Daniel Surinach as executive officer and director.
Daniel Surinach first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Daniel Surinach in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Daniel Surinach works with at each company, as listed on that company's latest Form D.
Objective Biotechnology, Inc. · Form D, Nov 26, 2024
JG
James Grabau
CEO
AJ
Amey Joshi
Executive officer and director
SK
Suhasa Kodandaramaiah
Executive officer and director
AA
Andrew Alegria
Executive officer and director
DG
Daryl Gohl
Executive officer and director